The Efficacy of Equine Assisted Occupational Therapy for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation
The Efficacy of Attention Skill Therapy (ASTride), an Equine Assisted Occupational Therapy Intervention, for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation
1 other identifier
interventional
50
1 country
1
Brief Summary
The goal of this clinical trial is to develop and validate an Equine Assisted Occupational Therapy Intervention for children aged 6-12 with Attention Deficit Hyperactivity Disorder. The research aims to study the effect of an EAOT intervention on cognitive-emotional aspects, daily function and participation among these children using various measurements including physiological measures (EEG, heart rate for rider and horse), questionnaires and different tasks. It aims to enable the creation of an evidence based protocol for professionals in order to provide a better suited therapy for children with ADHD and enable them to live a full life. Participants will enroll in a 12 week EAOT intervention including one session per week of 45 minutes with a waiting period prior the intervention. Participants will go through assessments prior waiting time, prior the intervention and post intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2023
CompletedFirst Submitted
Initial submission to the registry
May 11, 2023
CompletedFirst Posted
Study publicly available on registry
May 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedSeptember 8, 2025
September 1, 2025
2 years
May 11, 2023
September 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Behavior Rating Inventory of Executive Function (BRIEF) (Gioia, Isquith, Guy, & Kenworthy, 2000)
standardized ecological rating scale filled by a parent, designed to reflect the neuropsychological constructs of EF in everyday situations for children aged 5-18
3 months
Secondary Outcomes (10)
the Tower of Hanoi test (Lezak et al., 2004).
3 months
The Brain Engagement Index; BEI (Shahaf et al., 2018)
3 months
The new General Self-efficacy Scale (NGSE)
3 months
The Screen for Child Anxiety Related Emotional Disorders (SCARED)
3 months
The Hebrew adaptation of The Children's Hope Scale (Snyder, 2002)
3 months
- +5 more secondary outcomes
Study Arms (1)
children diagnosed with ADHD
EXPERIMENTALAfter completing an eligibility assessment, adequate participants will go through baseline assessment and 12 weeks of waiting without receiving intervention; b) pre-test, before first treatment session, end of 12 week waiting period; c) post-test after 12 weeks of intervention; d) post intervention assessment, three months follow up
Interventions
: A prospective cohort study with Interrupted Time-Series design will be conducted. Forty participants and their parents who were referred to EAOT will be recruited from the waiting list of Harey Yehuda stables. Assessments will take place at four time points. Time 1: baseline-when referred for EAOT. Time 2: pre-test, before first treatment session, end of 12 week waiting period. Time 3: post-test after 12 weeks of intervention and time 4: post intervention assessment, three months follow up. The intervention will be administered by a licensed EAOT, and assessments will be done by a blinded licensed occupational therapist (OT). Standardized assessment measures will be used to measure EFs, cognitive-emotional and sensory-motor aspects as well as participation at each time point.
Eligibility Criteria
You may qualify if:
- Children between 6 and 12 years of age
- Diagnosis of ADHD from a medical professional based on DSM-5 criteria with or without medication (e.g., psychostimulant medication)
- General doctors' approval and referral for participating in EAS
You may not qualify if:
- Moderate to severe cognitive impairment
- Neurological disorders (e.g., epilepsy)
- Children with additional developmental disorders (e.g., Autism, Cerebral Palsy)
- Children who will begin new medicine treatment or change existing treatment during intervention
- Children with severe sensory loss (e.g., blindness).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tel Aviv University
Tel Aviv, Israel, 69978, Israel
Related Publications (1)
Helmer A, Delore E, Bart O. Horses and ADHD: the ASTride intervention for cognitive and emotional growth. Child Adolesc Psychiatry Ment Health. 2025 Nov 21;19(1):131. doi: 10.1186/s13034-025-00990-6.
PMID: 41272733DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- The intervention will be administered by a licensed EAOT, and assessments will be done by a blinded licensed occupational therapist (OT).
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lead investigator
Study Record Dates
First Submitted
May 11, 2023
First Posted
May 22, 2023
Study Start
February 1, 2023
Primary Completion
February 1, 2025
Study Completion
February 1, 2025
Last Updated
September 8, 2025
Record last verified: 2025-09